Cognitive behavioral therapy for substance use disorders

Psychiatric Clinics of North America

Volumn 33, Issue 3, 2010, Pages 511-525

  McHugh R Kathryn, R K ^a   Hearon, Bridget A ^a   Otto, Michael W ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Cognitive behavioral therapy; Contingency management; Motivational interviewing; Relapse prevention; Substance use disorders

Indexed keywords

ACAMPROSATE; CYCLOSERINE; NALTREXONE; PSYCHOTROPIC AGENT;

ALCOHOLISM; AMBIVALENCE; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; DRUG DEPENDENCE; DRUG EFFICACY; HUMAN; MOTIVATION; NEUROTRANSMISSION; NONHUMAN; PATIENT ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SOCIAL BEHAVIOR; SUBSTANCE ABUSE; SUPPORT GROUP; TREATMENT RESPONSE; MULTIMODALITY CANCER THERAPY; PROCEDURES; SUBSTANCE-RELATED DISORDERS;

COGNITIVE THERAPY; COMBINED MODALITY THERAPY; HUMANS; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 77954249070     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2010.04.012     Document Type: Review

References (78)

1. Compton W.M., Thomas Y.F., Stinson F.S., et al. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2007, 64:566-576.
2. Hasin D.S., Stinson F.S., Ogburn E., et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2007, 64:830-842.
3. Vidrine J.I., Cofta-Woerpel L., Daza P., et al. Smoking cessation 2: behavioral treatments. Behav Med 2006, 32:99-109.
4. Dutra L., Stathopoulou G., Basden S.L., et al. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008, 165:179-187.
5. Magill M., Ray L.A. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs 2009, 70:516-527.
6. Carroll K.M., Rounsaville B.J., Nich C., et al. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Arch Gen Psychiatry 1994, 51:989-997.
7. Rawson R.A., Huber A., McCann M., et al. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry 2002, 59:817-824.
8. Miller W.R., Rollnick S. Motivational interviewing: preparing people for change 2002, Guilford Press, New York. 2nd edition.
9. Merlo L.J., Storch E.A., Lehmkuhl H.D., et al. Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: a preliminary study. Cogn Behav Ther 2009, 1:24-27.
10. Simpson H.B., Zuckoff A., Page J.R., et al. Adding motivational interviewing to exposure and ritual prevention for obsessive-compulsive disorder: an open pilot trial. Cogn Behav Ther 2008, 37:38-49.
11. Westra H.A., Arkowitz H., Dozois D.J. Adding a motivational interviewing pretreatment to cognitive behavioral therapy for generalized anxiety disorder: a preliminary randomized controlled trial. J Anxiety Disord 2009, 23:1106-1117.
12. Burke B.L., Arkowitz H., Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol 2003, 71:843-861.
13. Petry N.M., Martin B., Cooney J.L., et al. Give them prizes, and they will come: contingency management for treatment of alcohol dependence. J Consult Clin Psychol 2000, 68:250-257.
14. Higgins S.T., Wong C.J., Badger G.J., et al. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. J Consult Clin Psychol 2000, 68:64-72.
15. Petry N.M., Martin B. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J Consult Clin Psychol 2002, 70:398-405.
16. Prendergast M., Podus D., Finney J., et al. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006, 101:1546-1560.
17. Sindelar J., Elbel B., Petry N.M. What do we get for our money? Cost-effectiveness of adding contingency management. Addiction 2007, 102:309-316.
18. Stitzer M., Petry N. Contingency management for treatment of substance abuse. Annu Rev Clin Psychol 2006, 2:411-434.
19. Carroll K.M., Ball S.A., Nich C., et al. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch Gen Psychiatry 2001, 58:755-761.
20. Elk R., Mangus L., Rhoades H., et al. Cessation of cocaine use during pregnancy: effects of contingency management interventions on maintaining abstinence and complying with prenatal care. Addict Behav 1998, 23:57-64.
21. DeFulio A., Donlin W.D., Wong C.J., et al. Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: a randomized controlled trial. Addiction 2009, 104:1530-1538.
22. Silverman K., Wong C.J., Needham M., et al. A randomized trial of employment-based reinforcement of cocaine abstinence in injection drug users. J Appl Behav Anal 2007, 40:387-410.
23. Relapse prevention: maintenance strategies in the treatment of addictive behaviors 1985, Guilford Press, New York. G.A. Marlatt, J.R. Gordon (Eds.).
24. Irvin J.E., Bowers C.A., Dunn M.E., et al. Efficacy and relapse prevention: a meta-analytic review. J Consult Clin Psychol 1999, 67:563-570.
25. Carroll K.M. A cognitive-behavioral approach: treating cocaine addiction 1998, National Institute on Drug Abuse, Rockville (MD).
26. Hunt G.M., Azrin N.H. A community reinforcement approach to alcoholism. Behav Res Ther 1973, 11:91-104.
27. Finney J.W., Monahan S.C. The cost-effectiveness of treatment for alcoholism: a second approximation. J Stud Alcohol 1996, 57:229-243.
28. Holder H., Longabaugh R., Miller W.R., et al. The cost effectiveness of treatment for alcoholism: a first approximation. J Stud Alcohol 1991, 52:517-540.
29. Miller W.R., Brown J.M., Simpson T.L., et al. What works? A methodological analysis of the alcohol treatment outcome literature. Handbook of alcoholism treatment approaches: effective alternatives 1995, 12-44. Allyn & Bacon, Needham (MA). R.K. Hester, W.R. Miller (Eds.).
30. Higgins S.T., Budney A.J., Bickel W.K., et al. Outpatient behavioral treatment for cocaine dependence one-year outcome. Exp Clin Psychopharmacol 1995, 3:205-212.
31. Abbott P.J., Weller S.B., Delaney H.D., et al. Community reinforcement approach in the treatment of opiate addicts. Am J Drug Alcohol Abuse 1998, 24:17-30.
32. Epstein E.E., McCrady B.S. Behavioral couples treatment of alcohol and drug use disorders: current status and innovations. Clin Psychol Rev 1998, 18:689-711.
33. O'Farrell T.J., Fals-Stewart W. Behavioral couples therapy for alcoholism and drug abuse 2006, Guilford Press, New York.
34. Powers M.B., Vedel E., Emmelkamp M.G. Behavioral couples therapy (BCT) for alcohol and drug use disorders: a meta-analysis. Clin Psychol Rev 2008, 28:952-962.
35. Stanton D.M., Shadish W.R. Outcome, attrition, and family-couples treatment for drug abuse: a meta-analysis and review of the controlled, comparative studies. Psychol Bull 1997, 122:170-191.
36. Otto M.W., Smits J.A.J., Reese H.E. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: review and analysis. Clin Psychol Sci Pract 2005, 12:72-86.
37. Anton R.F., Moak D.H., Latham P., et al. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol 2005, 25:349-357.
38. Feeney G.F., Connor J.P., Young R.M., et al. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy. Alcohol Alcohol 2006, 41:321-327.
39. Walters D., Connor J.P., Feeney G.F., et al. The cost effectiveness of naltrexone added to cognitive-behavioral therapy in the treatment of alcohol dependence. J Addict Dis 2009, 28:137-144.
40. Anton R.F., O'Malley S.S., Ciraulo D.A., et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the combine study: a randomized controlled trial. JAMA 2006, 295:2003-2017.
41. Carroll K.M., Fenton L.R., Ball S.A., et al. Efficacy of disulfiram and cognitive behavioral therapy in cocaine-dependent outpatients; a randomized placebo-controlled trial. Arch Gen Psychiatry 2004, 61:264-272.
42. Moeller F.G., Schmitz J.M., Steinberg J.L., et al. Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial. Am J Drug Alcohol Abuse 2007, 33:367-378.
43. Kavanagh D.J., Sitharthan G., Young R.M., et al. Addition of cue exposure to cognitive-behaviour therapy for alcohol misuse: a randomized trial with dysphoric drinkers. Addiction 2006, 101:1106-1116.
44. Vedel E., Emmelkamp P.M., Schippers G.M. Individual cognitive-behavioral therapy and behavioral couples therapy in alcohol use disorder: a comparative evaluation in community-based addiction treatment centers. Psychother Psychosom 2008, 77:280-288.
45. Rawson R.A., McCann M.J., Flammino F., et al. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction 2006, 101:267-274.
46. Project MATCH Research Group Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 1997, 58:7-29.
47. Project MATCH Research Group Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcohol Clin Exp Res 1998, 22:1300-1311.
48. Higgins S.T., Budney A.J., Bickel W.K., et al. Incentives improve outcomes in outpatient behavioral treatment of cocaine-dependence. Arch Gen Psychiatry 1994, 51:568-576.
49. Silverman K., Wong C.J., Higgins S.T., et al. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend 1996, 41:157-165.
50. Silverman K., Wong C.J., Umbricht-Schneiter A., et al. Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. J Consult Clin Psychol 1998, 66:811-824.
51. Carroll K.M., Martino S., Ball S.A., et al. A multisite randomized effectiveness trial of motivational enhancement therapy for Spanish-speaking substance users. J Consult Clin Psychol 2009, 77:993-999.
52. Ball S.A., Martino S., Nich C., et al. Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol 2007, 75:556-567.
53. Gray E., McCambridge J., Strang J. The effectiveness of motivational interviewing delivered by youth workers in reducing drinking, cigarette, and cannabis smoking among young people: quasi-experimental pilot study. Alcohol Alcohol 2005, 40:535-539.
54. Carroll K.M., Ball S.A., Nich C., et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend 2006, 81:301-312.
55. McCrady B.S., Ziedonis D. American Psychiatric Association practice guideline for substance use disorders. Behav Med 2001, 32:309-336.
56. Miller W.R., Hester R. Inpatient alcoholism treatment: who benefits?. Am Psychol 1986, 41:794-805.
57. Cosci F., Schruers K.R., Abrams K., et al. Alcohol use disorders and panic disorder: a review of the evidence of a direct relationship. J Clin Psychiatry 2007, 68:874-880.
58. Cooper M.L. Motivations for alcohol use among adolescents: development and validation of a four-factor model. Psychol Assess 1994, 6:117-128.
59. Grant V.V., Stewart S.H., Mohr C.D. Coping-anxiety and coping-depression motives predict different daily mood-drinking relationships. Psychol Addict Behav 2009, 23:226-237.
60. Otto M.W., O' Cleirigh C.M., Pollack M.H. Attending to emotional cues for drug abuse: bridging the gap between clinic and home behaviors. Sci Pract Perspect 2007, 3:48-56.
61. Monti P.M., Rohsenow D.J., Swift R.M., et al. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Alcohol Clin Exp Res 2001, 25:1634-1647.
62. Rohsenow D.J., Monti P.M., Rubonis A.V., et al. Cue exposure with coping skills training and communication skills training for alcohol dependence: 6- and 12-month outcomes. Addiction 2001, 96:1161-1174.
63. Otto M.W., Safren S.A., Pollack M.H. Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder. J Anxiety Disord 2004, 18:69-87.
64. Pollack M.H., Penava S.A., Bolton E., et al. A novel cognitive-behavioral approach for treatment-resistant drug dependence. J Subst Abuse Treat 2002, 23:335-342.
65. Zvolensky M.J., Lejuez C.W., Kahler C.W., et al. Integrating an interoceptive exposure-based smoking cessation program into the cognitive-behavioral treatment of panic disorder: theoretical relevance and case demonstration. Cogn Behav Pract 2003, 10:347-357.
66. Zvolensky M.J., Yartz A.R., Gregor K., et al. Interoceptive exposure-based cessation intervention for smokers high in anxiety sensitivity: a case series. J Cogn Psychother 2008, 22:347-366.
67. Reynolds B. A review of delay-discounting research with humans: relations to drug use and gambling. Behav Pharmacol 2006, 17:651-667.
68. Carroll K.M., Ball S.A., Martino S., et al. Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT. Am J Psychiatry 2008, 165:881-888.
69. Carroll K.M., Ball S.A., Martino S., et al. Enduring effects of a computer-assisted training program for cognitive behavioral therapy: a 6-month follow-up of CBT4CBT. Drug Alcohol Depend 2009, 100:178-181.
70. Hood W.F., Compton R.P., Monahan J.B. d-Cycloserine: a ligand for the N-methyl-d-aspartate coupled glycine receptor has partial agonist characteristics. Neurosci Lett 1989, 98:91-95.
71. Otto M.W., Basden S.L., Leyro T.M., et al. Clinical perspectives on the combination of d-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders. CNS Spectr 2007, 12:51-56. 59-61.
72. Dhonnchadha B.A.N., Szalay J.J., Achat-Mendes C., et al. d-Cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning. Neuropsychopharmacology 2009, 2:357-367.
73. Groblewski P.A., Lattal K.M., Cunningham C.L. Effects of d-cycloserine on extinction and reconditioning of ethanol-seeking behavior in mice. Alcohol Clin Exp Res 2009, 33:772-782.
74. Myers K.M., Carlezon W.A. d-Cycloserine facilitates extinction of naloxone-induced place aversion in morphine-dependent rats. Biol Psychiatry 2010, 67:85-87.
75. Condon T.P., Miner L.L., Balmer C.W., et al. Blending addiction and research and practice: strategies for technology transfer. J Subst Abuse Treat 2008, 35:156-160.
76. Cook J.M., Walser R.D., Kane V., et al. Dissemination and feasibility of a cognitive-behavioral treatment for substance use disorders and posttraumatic stress disorder in the veterans administration. J Psychoactive Drugs 2006, 38:89-92.
77. McHugo G.J., Drake R.E., Whitley R., et al. Fidelity outcomes in the National Implementing Evidence-based Practices Project. Psychiatr Serv 2007, 58:1279-1284.
78. Squires D.D., Gumbley S.J., Storti S.A. Training substance abuse treatment organizations to adopt evidence-based practices: the Addiction Technology Transfer Center of New England Science to Service Laboratory. J Subst Abuse Treat 2008, 34:293-301.